Raymond B. Birge

9.8k citations

112 papers · 7.6k indexed · 2 hit papers · h-index 47

Immunology top 0.5%
- Phagocytosis and Immune Regulation 47
Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 14
Cell Biology top 1%
Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling 18
- Cell death mechanisms and regulation 9
Pharmacology top 1%
- Drug-Induced Hepatotoxicity and Protection 12
Physiology
- Erythrocyte Function and Pathophysiology 27
Oncology
- Drug Transport and Resistance Mechanisms 8
Hematology
- Chronic Myeloid Leukemia Treatments 8

Co-authors: Hidesaburô Hanafusa Yi Wu J. Eduardo FajardoSushil KumarMatthew L. Albert Sukhwinder Singh David Calianese Charles Reichman
Cited by: Immunology Immunology and Allergy Cell Biology
Journals: Nature (1 paper)Science (1 paper)Journal of Biological Chemistry (12 papers)
Partner nations: United States China Japan

In The Last Decade

Raymond B. Birge

109 papers receiving 7.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Raymond B. Birge

Since Specialization

Citations

This map shows the geographic impact of Raymond B. Birge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond B. Birge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond B. Birge more than expected).

Fields of papers citing papers by Raymond B. Birge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond B. Birge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond B. Birge. The network helps show where Raymond B. Birge may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raymond B. Birge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raymond B. Birge Line = papers co-authored together Raymond B. Birge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AAV-mediated BDNF and GAS6 muscle delivery delays disease onset in SOD1G93A ALS mice Gene Therapy ·Yicong Le,Gongjie Liu,Songwei Wu,Marialaina Nissenbaum,Alexander W. Kusnecov,Philip Furmanski,Raymond B. Birge,Renping Zhou	2025	0
2	Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing International Journal of Molecular Sciences ·Kevin C. Lahey,Christopher Varsanyi,Ziren Wang,Ahmed Aquib,Varsha Gadiyar,Alcina A. Rodrigues,Rachael Pulica,Samuel Desind,Viralkumar Davra,David Calianese,Dongfang Liu,Jong-Hyun Cho,Sergei V. Kotenko,Mariana S. De Lorenzo,Raymond B. Birge	2024	6
3	Expression, purification and characterization of phosphatidylserine-targeting antibodies for biochemical and therapeutic applications Methods in cell biology ·Varsha Gadiyar,David Calianese,Rachael Pulica,Christopher Varsanyi,Ziren Wang,Ahmed Aquib,Alok Choudhary,Raymond B. Birge	2024	0
4	Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders Frontiers in Immunology ·Varsha Gadiyar,Gopi Patel,Jesse Chen,Dominico Vigil,Nan Ji,Veronica A. Campbell,Kirti Sharma,Yatao Shi,Matthew M. Weiss,Raymond B. Birge,Viralkumar Davra	2023	8
5	Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti‐PDL1 efficacy in head and neck cancer Head & Neck ·Kourtney L. Kostecki,Mari Iida,Anne L. Wiley,Stanley Kimani,Bridget Mehall,Kaitlin Tetreault,Roxana Alexandridis,Menggang Yu,Seungpyo Hong,Ravi Salgia,Justine Y. Bruce,Raymond B. Birge,Paul M. Harari,Deric L. Wheeler	2023	7
6	Critical role of interferons in gastrointestinal injury repair Nature Communications ·McElrath Constance,Vanessa Espinosa,Jian-Da Lin,Peng Jianya,Raghavendra Rao Sridhar,Orchi Dutta,Tseng Hsiang-Chi,Smirnov Sv,Heidi P. Risman,Marvin J. Sandoval,Viralkumar Davra,Yun‐Juan Chang,Brian P. Pollack,Raymond B. Birge,Mark Galan,Amariliz Rivera,Joan E. Durbin,Sergei V. Kotenko	2021	50
7	Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity Cancer Research ·Viralkumar Davra,Sushil Kumar,Ke Geng,David Calianese,Dhriti Mehta,Varsha Gadiyar,Canan Kasikara,Kevin C. Lahey,Yun‐Juan Chang,Michael Wichroski,Chan Gao,Mariana S. De Lorenzo,Sergei V. Kotenko,Tessa Bergsbaken,Pankaj Kumar Mishra,William C. Gause,Michael Quigley,Thomas Spires,Raymond B. Birge	2020	61
8	Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis Cell Metabolism ·Bishuang Cai,Paola Dongiovanni,Kathleen E. Corey,Xiaobo Wang,Igor Shmarakov,Ze Zheng,Canan Kasikara,Viralkumar Davra,Marica Meroni,Raymond T. Chung,Carla V. Rothlin,Robert F. Schwabe,William S. Blaner,Raymond B. Birge,Luca Valenti,Ira Tabas	2019	192
9	Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment Breast Cancer Research ·Alison E. Obr,Sushil Kumar,Yun‐Juan Chang,Joseph J. Bulatowicz,Betsy Barnes,Raymond B. Birge,Deborah A. Lazzarino,Emily J. Gallagher,Derek LeRoith,Teresa L. Wood	2018	34
10	Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6 Frontiers in Immunology ·Ke Geng,Sushil Kumar,Stanley Kimani,Vladyslav Kholodovych,Canan Kasikara,Kensaku Mizuno,Oleta A. Sandiford,Pranela Rameshwar,Sergei V. Kotenko,Raymond B. Birge	2017	69
11	Efferocytosis Current Biology ·Sushil Kumar,Raymond B. Birge	2016	48
12	Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk Oncogene ·Ganesh Sriram,Wojciech Jankowski,Canan Kasikara,Charles Reichman,Tamjeed Saleh,K-Q Nguyen,Jiawei Li,Peter Hornbeck,Kazuya Machida,Tao Liu,Hong Li,Charalampos G. Kalodimos,Raymond B. Birge	2014	8
13	Commentary: The carboxyl‐terminal Crk SH3 domain: Regulatory strategies and new perspectives FEBS Letters ·Ganapathy Sriram,Raymond B. Birge	2012	7
14	Real-time Fluorescent Resonance Energy Transfer Analysis to Monitor Drug Resistance in Chronic Myelogenous Leukemia Molecular Cancer Therapeutics ·Ahmet Tunceroglu,Michiyuki Matsuda,Raymond B. Birge	2010	18
15	Control of Alzheimer's Amyloid Beta Toxicity by the High Molecular Weight Immunophilin FKBP52 and Copper Homeostasis in Drosophila PLoS ONE ·Reiko Sanokawa‐Akakura,Weihuan Cao,Kirsten Allan,Khyati Patel,Anupama Ganesh,Gary A. Heiman,Richard Burke,Francis W. Kemp,John D. Bogden,James Camakaris,Raymond B. Birge,Mary Konsolaki	2010	53
16	Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain Oncogene ·Charles Reichman,Kamalendra Singh,Yan Liu,Sukhwinder Singh,Hong Li,J. Eduardo Fajardo,András Fiser,Raymond B. Birge	2005	27
17	A comparison of proteins S-thiolated by glutathione to those arylated by acetaminophen Biochemical Pharmacology ·Raymond B. Birge,John B. Bartolone,Steven D. Cohen,Edward A. Khairallah,Lori A. Smolin	1991	22
18	Acetaminophen hepatotoxicity: Correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo Toxicology and Applied Pharmacology ·Raymond B. Birge,John B. Bartolone,Susan Hart,Ervant V. Nishanian,Charles A. Tyson,Edward A. Khairallah,Steven D. Cohen	1990	43
19	Selective protein arylation by acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice Biochemical Pharmacology ·Raymond B. Birge,John B. Bartolone,Denis McCann,James B. Mangold,Steven D. Cohen,Edward A. Khairallah	1989	26
20	Dissociation of covalent binding from the oxidative effects of acetaminophen Biochemical Pharmacology ·Raymond B. Birge,John B. Bartolone,Ervant V. Nishanian,Mary K. Bruno,James B. Mangold,Steven D. Cohen,Edward A. Khairallah	1988	37

About Raymond B. Birge

Raymond B. Birge is a scholar working on Immunology, Immunology and Allergy and Pharmacology, having authored 112 papers that have together received 7.6k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (47 papers), Erythrocyte Function and Pathophysiology (27 papers), Protein Kinase Regulation and GTPase Signaling (18 papers), Cell Adhesion Molecules Research (14 papers), Drug-Induced Hepatotoxicity and Protection (12 papers), Cell death mechanisms and regulation (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Immunology (3.2k citations), Immunology and Allergy (836 citations) and Cell Biology (1.0k citations). Raymond B. Birge has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Hidesaburô Hanafusa, Yi Wu, J. Eduardo Fajardo, Sushil Kumar, Matthew L. Albert, Sukhwinder Singh, David Calianese, Charles Reichman, Bruce J. Mayer and Viralkumar Davra. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact